Given the lack of effective therapies against sepsis- and ARDS-induced pulmonary fibrosis [18], targeting the TGF-β/PI3K axis represents a potential strategy to reduce lung fibroproliferation. Here, PIK3CD is linked to acute respiratory distress syndrome.